These results suggested that, in addition to promoting apoptotic cell death in cancer cells, RCF + Ixz may reduce the pro-tumorigenic effects of extracellularly secreted Cyp and CD147 function to further improve efficacy. The gene discussed is BSG; the disease is cancer.